These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 14627751)

  • 1. Economic analysis of a school-based obesity prevention program.
    Wang LY; Yang Q; Lowry R; Wechsler H
    Obes Res; 2003 Nov; 11(11):1313-24. PubMed ID: 14627751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a school-based obesity prevention program.
    Wang LY; Gutin B; Barbeau P; Moore JB; Hanes J; Johnson MH; Cavnar M; Thornburg J; Yin Z
    J Sch Health; 2008 Dec; 78(12):619-24. PubMed ID: 19000237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic effect of Planet Health on preventing bulimia nervosa.
    Wang LY; Nichols LP; Austin SB
    Arch Pediatr Adolesc Med; 2011 Aug; 165(8):756-62. PubMed ID: 21810638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
    Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
    Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a family-based GP-mediated intervention targeting overweight and moderately obese children.
    Moodie M; Haby M; Wake M; Gold L; Carter R
    Econ Hum Biol; 2008 Dec; 6(3):363-76. PubMed ID: 18657487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of Australia's Active After-School Communities program.
    Moodie ML; Carter RC; Swinburn BA; Haby MM
    Obesity (Silver Spring); 2010 Aug; 18(8):1585-92. PubMed ID: 19893504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. School-based smoking prevention: economic costs versus benefits.
    Stephens T; Kaiserman MJ; McCall DJ; Sutherland-Brown C
    Chronic Dis Can; 2000; 21(2):62-7. PubMed ID: 11007656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic analysis of prevention: an illustration involving children's behavior problems.
    Foster EM; Jones DE
    J Ment Health Policy Econ; 2007 Dec; 10(4):165-75. PubMed ID: 18166828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to assessing the health benefit from obesity interventions in children and adolescents: the assessing cost-effectiveness in obesity project.
    Haby MM; Vos T; Carter R; Moodie M; Markwick A; Magnus A; Tay-Teo KS; Swinburn B
    Int J Obes (Lond); 2006 Oct; 30(10):1463-75. PubMed ID: 17003807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term health and economic impact of preventing and reducing overweight and obesity in adolescence.
    Wang LY; Denniston M; Lee S; Galuska D; Lowry R
    J Adolesc Health; 2010 May; 46(5):467-73. PubMed ID: 20413083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of a primary care trial to reduce weight gain in overweight/obese children: the LEAP trial.
    Wake M; Gold L; McCallum Z; Gerner B; Waters E
    Ambul Pediatr; 2008; 8(5):336-41. PubMed ID: 18922508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.